An isoflavone with diverse biological activities
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Calycosin

Item No. 25091

Technical Information
Formal Name
7-hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one
CAS Number
20575-57-9
Molecular Formula
C16H12O5
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 30 mg/mlDMSO: 25 mg/ml
λmax
219, 249, 291 nm
SMILES
OC1=CC=C(C(C(C2=CC(O)=C(OC)C=C2)=CO3)=O)C3=C1
InChi Code
InChI=1S/C16H12O5/c1-20-14-5-2-9(6-13(14)18)12-8-21-15-7-10(17)3-4-11(15)16(12)19/h2-8,17-18H,1H3
InChi Key
ZZAJQOPSWWVMBI-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    Calycosin is an isoflavone and phytoestrogen with diverse biological activities.1,2,3,4,5,6 It is an estrogen receptor (ER) partial agonist that inhibits 17β-estradiol binding to ERα and ERβ (IC50s = 83.14 and 40.38 μM, respectively).1 Calycosin induces tube formation by human umbilical vein endothelial cells (HUVECs) in a Matrigel™ assay and angiogenesis in zebrafish via activation of ERs and ERK1/2. It has antiplasmodial and antiprotozoal activities, reducing the growth of the poW and Dd2 strains of P. falciparum (IC50s = 4.2 and 9.8 μg/ml, respectively) and exhibiting selective toxicity for T. brucei brucei over Vero cells (IC50s = 12.7 and 159 μM, respectively).2,3 Calycosin scavenges 2,2-diphenyl-1-picrylhydrazyl (DPPH; Item No. 14805) free radicals in a cell-free assay and inhibits xanthine/xanthine oxidase-induced toxicity in PC12 cells (EC50 = 50 ng/ml).4 In vivo, calycosin (12.5 and 25 mg/kg) reduces alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, triglyceride accumulation, and hepatic fibrosis in a mouse model of non-alcoholic steatohepatitis (NASH).5 It also decreases infarct volume and brain edema in a rat model of focal cerebral ischemia and reperfusion injury.6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Tang, J.Y., Li, S., Li, Z.H., et alCalycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC. PLoS One 5(7):e11822, (2010).

    2. Kraft, C., Jenett-Siems, K., Siems, K., et alAntiplasmodial activity of isoflavones from Andira inermis. J. Ethnopharmacol. 73(1-2), 131-135 (2000).

    3. Salem, M.M., and Werbovetz, K.A. Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities. J. Nat. Prod. 69(1), 43-49 (2006).

    4. Yu, D.-H., Bao, Y.-M., Wei, C.-L., et alStudies of chemical constituents and their antioxidant activities from Astragalus mongholicus Bunge. Biomed. Environ. Sci. 18(5), 297-301 (2005).

    5. Duan, X., Meng, Q., Wang, C., et alCalycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor. Phytomedicine 25, 83-92 (2017).

    6. Wang, Y., Ren, Q., Zhang, X., et alNeuroprotective mechanisms of calycosin against focal cerebral ischemia and reperfusion injury in rats. Cell Physiol. Biochem. 45(2), 537-546 (2018).